Anatomical and electrophysiological studies have demonstrated that enkephalinergic, noradrenergic, and serotonergic pathways projecting from the brain-stem to the dorsal horn inhibit nociceptive transmission at the spinal level. Previous attempts to delineate interactions between opioids, norepinephrine (NE), and serotonin (5-HT) in the production of spinal analgesia have produced conflicting results. The present study determined the effect of intrathecal (i.t.) pretreatment with opioid, NE, and 5-HT antagonists upon i.t. monoamine- and morphine-induced antinociception as assessed with the rat tail-flick model. Naloxone, at a dose which antagonized i.t. morphine analgesia, had no effect upon i.t. NE but inhibited i.t. 5-HT antinociception. Corynanthine or yohimbine (NE antagonists) reduced analgesia elicited by i.t. NE but not morphine, while pretreatment with methysergide or ketanserin (5-HT antagonists) attenuated both i.t. 5-HT- and morphine-induced antinociception. These results suggest that an opioid link mediates spinal 5-HT but not NE antinociception, and 5-HT but not NE participates in spinal morphine analgesia.
This text is a reference source of information on safe and effective drug therapy. It provides information on the general principles of pharmacology, including pharmacokinetics, pharmacodynamics, methods of administration, adverse effects and drug interactions. Up-to-date drug information is conveniently organized by body system and presented in table format for easy access to specific information. Nursing management sections have been expanded to help students deliver exceptional patient care and address topics such as drug therapy interventions and patient education guidelines.
